When you’re talking about the demographic that has the least to gain from a particular medical treatment but the most to lose if (God forbid) there are long-term safety issues, I don’t think you get to say “let’s just roll this thing out and see how it goes” https://t.co/npDTuFaY12
— Eric (@The_OtherET) October 27, 2021
